Skip to search formSkip to main contentSkip to account menu

darifenacin hydrobromide

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Simple and sensitive RP-HPLC method was developed, optimized and validated for the determination of Potential Genotoxic… 
2014
2014
An isocratic stability-indicating reversed phase high performance liquid chromatographic method (RP-HPLC) was developed for… 
2014
2014
Darifenacin is a muscarinic M3 selective receptor antagonist, which is intended for symptomatic treatment of urge incontinence… 
2013
2013
During the process development in the laboratory, the purity of darifenacin hydrobromide has been tested by HPLC. Three byproduct… 
2013
2013
During the process development in the laboratory, the purity of darifenacin hydrobromide has been tested by HPLC. Three byproduct… 
2012
2012
A novel, accurate and precise RP-UFLC method for determination of darifenacin hydrobromide has been developed and validated… 
2011
2011
The development and validation of an analytical ultraviolet (UV) spectroscopic method to quantify Darifenacin hydrobromide as a… 
2009
2009
ZusammenfassungViele Patienten erhalten multiple urologische und nichturologische Medikationen parallel, was zu… 
2009
2009
Darifenacin Hydro bromide (Enablex) is a potent muscarinic M3 receptor antagonist, used for the treatment of overactive bladder… 
2007
2007
Darifenacin hydrobromide was synthesized from trans-4-hydroxy-L-proline by decarboxylation, N-protection, Mitsunobu reaction…